ABSTRACT
Polypharmacy of elderly oncology patients and fragmented medication management are well-known risk factors for drug-drug interactions (DDIs). These interactions can occur among antineoplastic, ongoing chronic treatment(s) and chemotherapy-associated treatments, like antiemetics. Clinically relevant interactions based on enzyme- or transporter-inhibition phenomena of active drugs can increase the frequency of their DDIs. We describe a strongly suspected elderly cancer patient's DDI between aprepitant and opium powder in the context of an irinotecan-based regimen manifested by nightmares and visual hallucinations. We discuss this DDI's hypothetical pharmacological mechanisms and management.
Subject(s)
Aprepitant/pharmacology , Dreams/drug effects , Hallucinations/chemically induced , Opium/pharmacology , Polypharmacy , Adenocarcinoma/drug therapy , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Aprepitant/therapeutic use , Arthralgia/drug therapy , Camptothecin/adverse effects , Camptothecin/analogs & derivatives , Drug Interactions , Fluorouracil/adverse effects , Humans , Leucovorin/adverse effects , Male , Nausea/chemically induced , Nausea/prevention & control , Opium/therapeutic use , Powders , Sigmoid Neoplasms/drug therapyABSTRACT
The molecular and cellular actions of three classes of abused drugs--opiates, psychostimulants, and ethanol--are reviewed in the context of behavioral studies of drug dependence. The immediate effects of drugs are compared to those observed after long-term exposure. A neurobiological basis for drug dependence is proposed from the linkage between the cellular and behavioral effects of these drugs.
Subject(s)
Brain/physiopathology , Cocaine/pharmacology , Ethanol/pharmacology , Opium/pharmacology , Substance-Related Disorders/physiopathology , Animals , Behavior, Animal/drug effects , Drug Tolerance , Humans , Neurotransmitter Agents/physiology , Reinforcement, PsychologyABSTRACT
BACKGROUND: This experimental study was performed to determine the impact of opium use on serum lipid profile and glucose metabolism in rats with streptozotocin-induced diabetes. MATERIAL AND METHODS: To determine the effect of opium, 20 male rats were divided into control (n = 10) and opium-treated (n = 10) groups. After diabetes induction, the animals were investigated for daily glucose measurements for 35 days. Serum lipid profile and haemoglobin A1c (HbA(1c)) were assayed at the baseline (before induction of diabetes) and at 35-day follow-up. RESULTS: The glycaemia levels in the rats treated with opium were similar to the levels measured in the control rats (544.8 +/- 62.2 mg/dl v. 524.6 +/- 50.0 mg/dl, P = 0.434). In addition, there was no difference between the opium-treated rats and control rats in HbA(1c) (6.5 +/- 0.5% v. 6.6 +/- 0.2%, P = 0.714). Compared to the control rats, the serum total cholesterol, high density lipoprotein (HDL), triglyceride and lipoprotein (a) in the test animals were similar. CONCLUSION: Opium use has no significant effect on glucose metabolism and serum lipid profile in rats with induced diabetes.
Subject(s)
Analgesics, Opioid/pharmacology , Diabetes Mellitus, Experimental/metabolism , Glucose/metabolism , Lipid Metabolism/drug effects , Opium/pharmacology , Analysis of Variance , Animals , Glycated Hemoglobin/drug effects , Male , Rats , Rats, Sprague-DawleyABSTRACT
To determine the effects of opium on serum glucose, potassium and sodium in male and female Wistar rat, opium solution (60 mg/kg) injected intraperitoneally and the same volume of distilled water was used as control (7 rats in each group). Blood samples were collected at 0, 30, 60, 120, 240 and 360 minutes after injection from orbit cavity and the values of serum glucose, sodium (Na(+)) and potassium (K(+)) were measured. The data were then analyzed by the repeated measure ANOVA based on sex and case-control group. P < 0.05 considered as significant difference. Serum glucose increased significantly at 30, 60, 120 and 240 minutes after opium solution injection, in female rats compared to a control group. However, the male rats had this rise at 30, 60 and 120 minutes after opium solution injection compared to control group. While serum glucose in male rats was significantly higher than females at 30, 60 and 120 minutes, this value was higher in the female rats at 360 minutes. Therefore, serum glucose alterations following opium injection was significantly different in groups and in the sexes at different times. Sodium (Na(+)) rose at 60, 240 and 360 minutes significantly in all rats compared to control group. However, sodium alteration following opium injection was significantly different only between treated and control groups but sex-independent at all times. Potassium (K(+)) increased significantly at 60, 120, 240 and 360 minutes in male rats, compared to a control group. In female rats K(+) significantly raised at 30, 120, 240 and 360 minutes. Therefore, the alteration of K(+) in male and female rats was found time dependent and sex independent. According to our results, opium increased serum glucose in male and female rats differently, and it interferes with metabolic pathways differently on a gender dependent basis. Opium raised serum Na(+) and K(+), thus it interfere with water regulation and blood pressure via different mechanism.
Subject(s)
Blood Glucose/metabolism , Opium/pharmacology , Potassium/blood , Sodium/blood , Animals , Blood Glucose/drug effects , Female , Kinetics , Male , Rats , Rats, Wistar , Sex CharacteristicsABSTRACT
Paregoric elixir is a phytomedicinal product which is used widely as an analgesic, antispasmodic and antidiarrheal agent. Here, we investigated the pharmacological actions and some of the mechanisms of action of paregoric elixir and compared its action with some of its components, the alkaloids morphine and papaverine. The paregoric elixir given orally to mice did not present relevant toxic effects, even when administered in doses up to 2000-fold higher than those used clinically. However, it showed an antinociceptive action that was more potent, but less efficacious, than morphine. In contrast to morphine, its effect was not dose-dependent and not reversed by the non-selective opioid antagonist naloxone. Moreover, paregoric elixir produced tolerance, but did not cause cross-tolerance, with the antinociceptive actions of morphine. When assessed in the gastrointestinal motility in vivo, paregoric elixir elicited graduated reduction of gastrointestinal transit. Finally, like morphine and papaverine, paregoric elixir concentration-dependently inhibited electrically-induced contraction of the guinea pig isolated ileum. In vivo and in vitro gastrointestinal actions of paregoric elixir were not reversed by naloxone. Collectively, the present findings lead us to suggest that the pharmacological actions produced by paregoric elixir are probably due to a synergic action of its constituents.
Subject(s)
Opium/pharmacology , Analgesics/pharmacology , Analgesics, Opioid/pharmacology , Animals , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid , Drug Tolerance , Electric Stimulation , Female , Formaldehyde , Gastrointestinal Transit/drug effects , Lethal Dose 50 , Male , Mice , Morphine/pharmacology , Motor Activity/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Opium/chemistry , Opium/toxicity , Pain Measurement/drug effects , Papaverine/pharmacology , Parasympatholytics/pharmacology , Spectrophotometry, UltravioletABSTRACT
OBJECTIVE: The primary outcome of this study was to evaluate the effect of adding sufentanil to hyperbaric bupivacaine on duration of sensory blockade of spinal anesthesia in chronic opioid users in comparison with non-addicts. METHODS: Sixty patients scheduled for orthopedic surgery under spinal anesthesia were allocated into four groups: group 1 (no history of opium use who received intrathecal hyperbaric bupivacaine along with 1mL saline as placebo); group 2 (no history of opium use who received intrathecal bupivacaine along with 1mL sufentanil [5µg]); group 3 (positive history of opium use who received intrathecal bupivacaine along with 1mL saline as placebo) and group 4 (positive history of opium use who received intrathecal bupivacaine along with 1mL sufentanil [5µg]). The onset time and duration of sensory and motor blockade were measured. RESULTS: The duration of sensory blockade in group 3 was 120±23.1min which was significantly less than other groups (G1=148±28.7, G2=144±26.4, G4=139±24.7, p=0.007). The duration of motor blockade in group 3 was 145±30.0min which was significantly less than other groups (G1=164±36.0, G2=174±26.8, G4=174±24.9, p=0.03). CONCLUSIONS: Addition of 5µg intrathecal sufentanil to hyperbaric bupivacaine in chronic opioid users lengthened the sensory and motor duration of blockade to be equivalent to blockade measured in non-addicts.
Subject(s)
Analgesics, Opioid/pharmacology , Anesthesia, Spinal/methods , Bupivacaine/pharmacology , Opium/pharmacology , Substance-Related Disorders/complications , Sufentanil/pharmacology , Adult , Anesthetics, Local/pharmacology , Chronic Disease , Drug Therapy, Combination , Drug Users , Humans , Male , Time FactorsABSTRACT
We aimed to investigate the effect of perioperative analgesia with nonselective cyclooxygenase-2 inhibitor dexketoprofen and opioid drug omnopon on the functional activity of immune cells in tumor excision murine model. Lewis lung carcinoma cells were transplanted into hind paw of C57/black mice. On the 23th day tumor was removed. Analgesic drugs were injected 30 min before and once a day for 3 days after the surgery. Biological material was obtained a day before, 1 day and 3 days after the tumor removal. IFN-γ, IL-4, IL-10 and TGF-ß mRNA levels in splenic cells were assessed by quantitative real-time RT-PCR. Cytotoxic activity of splenocytes was estimated by flow cytometry. We found that in splenocytes of mice received opioid analgesia IL-10 mRNA level was increased 2.3 times on day one after the surgery compared to preoperative level (P < 0.05), while in dexketoprofen group this parameter did not change. IFN-γ gene expression level on day 3 after tumor removal was 40% higher in splenocytes of dexketoprofen treated mice as compared with omnopon treated animals (P < 0.05). Cytotoxic activity of splenocytes on day 3 postsurgery was (62.2 ± 2.4)% in dexketoprofen against (50.2 ± 3.3)% in omnopon group. In conclusion, perioperative analgesia with cyclooxygenase inhibitor dexketoprofen in contrast to opioid analgesia with omnopon preserves higher functional activity of murine immune cells in the experimental model of tumor surgery.
Subject(s)
Analgesics/pharmacology , Carcinoma, Lewis Lung/immunology , Cytotoxicity, Immunologic/drug effects , Ketoprofen/pharmacology , Lymphocytes/drug effects , Opium/pharmacology , Pain, Procedural/prevention & control , Animals , Carcinoma, Lewis Lung/genetics , Carcinoma, Lewis Lung/pathology , Carcinoma, Lewis Lung/surgery , Gene Expression , Hindlimb , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-4/genetics , Interleukin-4/immunology , Ketoprofen/analogs & derivatives , Lymphocytes/cytology , Lymphocytes/immunology , Mice , Mice, Inbred C57BL , Neoplasm Transplantation , Pain, Procedural/immunology , Pain, Procedural/physiopathology , Perioperative Period , RNA, Messenger/genetics , RNA, Messenger/immunology , Spleen/cytology , Spleen/drug effects , Spleen/immunology , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/immunologyABSTRACT
Memory tests were administered to 30 patients taking methadone hydrochloride and 31 taking levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) both prior to treatment and after one and three months of continuous treatment. A group of nonopiate using matched control subjects was administered the tests at similar intervals. No statistically significant difference in test performance was found among these groups at any of the three sessions. The methadone and control groups also did not differ significantly in the frequency of subjective reports of decreased memory function. Previous reports of memory deflicits during long-term methadone administration may be a result of comparing methadone and control groups at a single point in time and assuming that prior to methadone maintenance the groups were equivalent.
Subject(s)
Heroin Dependence/rehabilitation , Memory/drug effects , Methadone/analogs & derivatives , Methadone/pharmacology , Methadyl Acetate/pharmacology , Adult , Amphetamines/pharmacology , Barbiturates/pharmacology , Dose-Response Relationship, Drug , Female , Humans , Male , Opium/pharmacology , Psychological Tests , Research Design , Time FactorsABSTRACT
A patient developing acute pancreatitis with pseudocyst formation after an uncomplicated bone marrow harvest is reported. The diagnosis was confirmed by elevated serum amylase and lipase, and by CT scan. We suggest that the pancreatitis may have been precipitated by spasm of the sphincter of Oddi secondary to opiates administered as premedication and for pain relief.
Subject(s)
Analgesics, Opioid/adverse effects , Bone Marrow , Codeine/adverse effects , Common Bile Duct Diseases/chemically induced , Opium/adverse effects , Pancreatic Pseudocyst/etiology , Pancreatitis/etiology , Preanesthetic Medication/adverse effects , Tissue Donors , Abdominal Pain/chemically induced , Acute Disease , Amylases/blood , Analgesics, Opioid/pharmacology , Biomarkers , Bone Marrow Transplantation , Codeine/pharmacology , Humans , Lipase/blood , Male , Middle Aged , Opium/pharmacology , Pancreatic Pseudocyst/blood , Pancreatitis/blood , Spasm/chemically induced , Sphincter of Oddi/drug effectsABSTRACT
The effect of opiate analgesics (omnopon, pethidine, pentazocine) on the urethral mucosal sensitivity threshold in 37 patients, and of the potent opiate/opioid antagonist naloxone on 10 volunteers is described. Omnopon and pentazocine caused a significant decrease in sensitivity (p less than 0.02) and naloxone caused a significant increase in sensitivity (p less than 0.02). The results confirm a role for the endogenous opioids in modulating urethral sensitivity, and the implications of this are discussed.
Subject(s)
Analgesics, Opioid/pharmacology , Endorphins/antagonists & inhibitors , Naloxone/pharmacology , Sensation/drug effects , Urethra/drug effects , Endorphins/physiology , Humans , Male , Meperidine/pharmacology , Mucous Membrane/drug effects , Opium/pharmacology , Pentazocine/pharmacology , Receptors, Opioid/drug effects , Sensory Thresholds/drug effects , UrodynamicsABSTRACT
Previous studies have related opium and its pyrolysates to the risk of developing certain cancers. The aim of this work was to evaluate the clinical usefulness of determining carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) levels in habitual opium smokers. Serum CEA concentrations were measured in 128 opium smokers and in 44 controls of cigarette only smokers and 47 normal non-smokers by an EIA-based assay. TPA levels were also determined in serum and urine of a subgroup in the study population. The results indicated that serum CEA concentrations are higher in opium smokers than in healthy tobacco smokers (p = 0.004) and non-smokers (p = 0.001). The amount of opium used correlated with the serum CEA level (r = 0.276, p < 0.0001). The mean urine and serum TPA levels of the opium-addicted population were also higher than that of the non-smoking control group, but the differences were not statistically significant. We conclude that opium smoking is associated with elevated serum CEA levels. Therefore, for management of opium users with neoplastic diseases, increased levels of serum CEA should be viewed with caution to avoid misdiagnosis.
Subject(s)
Biomarkers, Tumor , Carcinoembryonic Antigen/blood , Opium/pharmacology , Tissue Polypeptide Antigen/biosynthesis , Adult , Aged , Case-Control Studies , Dose-Response Relationship, Drug , Female , Humans , Immunoenzyme Techniques , Male , Middle Aged , Neoplasms/diagnosis , Smoking , Substance-Related DisordersABSTRACT
Sedation for fibreoptic bronchoscopy should produce optimal conditions for the operator, patient comfort and rapid recovery allowing early discharge home. We have compared a regimen producing 'light' sedation with a more traditional regimen producing 'deep' sedation. Seventy-six patients undergoing fibreoptic bronchoscopy under topical anaesthesia were randomized to receive either light sedation with the short acting opiate, alfentanil (median dose 1.1 mg, range 0.5-2.6 mg) or deep sedation with a combination of papaveretum (median dose 10 mg, range 5-15 mg) and diazepam (median dose 8 mg, range 0-20 mg). Both techniques gave equally good operating conditions, although patients given alfentanil coughed less than those given papaveretum and diazepam (U = 2.814 P less than 0.01). Patients recorded their degree of apprehension on a visual analogue scale prior to sedation and the actual degree of comfort experienced after recovery. There was no significant difference between apprehension or comfort between the groups. This was despite a higher degree of amnesia for an irrelevant object shown during the bronchoscopy in the deeply sedated group (chi 2 = 21.084 P less than 0.001). Patients given alfentanil performed significantly better in a modified Romberg test (chi 2 = 4.357 P less than 0.05) and a visualisation test (t = 3.035 P less than 0.01) two hours after the bronchoscopy. Alfentanil produced good operating conditions, patient comfort, less cough and a more rapid recovery, compared to the deep sedation regimen, and is an ideal sedative for fibreoptic bronchoscopy.
Subject(s)
Alfentanil/pharmacology , Bronchoscopy , Diazepam/pharmacology , Fiber Optic Technology , Hypnotics and Sedatives/pharmacology , Opium/pharmacology , Aged , Dose-Response Relationship, Drug , Female , Humans , MaleABSTRACT
The pharmacokinetics of propofol were investigated in two groups of five Scottish blackface sheep undergoing surgery for the implantation of subcutaneous tissue pouches. After premedication with acepromazine and papaveretum, anaesthesia was induced with either propofol at 4 mg kg-1 intravenously (group 1) or with a mixture of propofol at 3 mg kg-1 and ketamine at 1 mg kg-1 intravenously (group 2). Anaesthesia was maintained with a variable infusion rate of either propofol alone (group 1) or propofol and ketamine (group 2). Both regimens produced satisfactory conditions for superficial surgery of the body surface. The mean (SD) duration of anaesthesia was 64.8 (3.1) minutes for group 1 and 60 (0) minutes for group 2; the mean total dose of propofol given to the sheep in group 1 was 801 (84) mg, and the sheep in group 2 received 470 (46) mg of propofol and 267 (30) mg of ketamine. The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2. There were wide variations in the blood propofol concentrations reached in individual sheep by using this standard dosing regimen. All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.
Subject(s)
Acepromazine/pharmacology , Anesthetics, Intravenous/pharmacokinetics , Dopamine Antagonists/pharmacology , Narcotics/pharmacology , Opium/pharmacology , Premedication/veterinary , Propofol/pharmacokinetics , Anesthetics, Intravenous/administration & dosage , Anesthetics, Intravenous/pharmacology , Animals , Female , Infusions, Intravenous , Ketamine/administration & dosage , Ketamine/pharmacology , Metabolic Clearance Rate , Propofol/administration & dosage , Propofol/pharmacology , Respiration/drug effects , Sheep , Systole/drug effectsABSTRACT
The effect of morphine, Tinct. opii, loperamide, pethidine and atropine on intestinal transit and the faecal and urinary excretion of water and electrolytes was studied in ponies. The rate of passage of a particulate marker was slowed by morphine, hastened then slowed by loperamide and Tinct. opii, and hastened by atropine. The liquid marker was slowed by Tinct. opii and hastened then slowed by the other drugs. Only loperamide decreased the faecal sodium excretion. This drug also decreased faecal water and weight; it appeared worthy of clinical trial in diarrhoea. Tinct. opii decreased by morphine, pethidine and atropine increased faecal water.
Subject(s)
Antidiarrheals/pharmacology , Electrolytes/analysis , Feces/analysis , Gastrointestinal Motility/drug effects , Horses/metabolism , Water/analysis , Animals , Atropine/pharmacology , Electrolytes/urine , Horses/physiology , Loperamide/pharmacology , Male , Meperidine/pharmacology , Morphine/pharmacology , Opium/pharmacologyABSTRACT
Forty dogs undergoing a variety of surgical procedures were assigned randomly to one of two groups. All the animals were premedicated with acepromazine (0.05 mg/kg bodyweight) intramuscularly, and anaesthesia was induced with thiopentone sodium, or propofol in the case of lean animals, and maintained with halothane in an oxygen/nitrous oxide mixture using a non-rebreathing circuit. The dogs in group 1 were given papaveretum (0.2 mg/kg) slowly intravenously within 35 minutes of induction of anaesthesia and the dogs in group 2 were given carprofen (4 mg/kg) in the same way. The dogs were scored for sedation and pain by a trained theatre nurse, who did not know which group they belonged to, using a visual analogue scale, at 15, 30, 60, 120, 240 and 360 minutes after the halothane was switched off at the end of the procedure. Nine of the dogs were withdrawn from the trial (eight of them from the papaveretum group) because of inadequate pain relief and these animals were given pethidine (3 mg/kg intramuscularly) which produced adequate analgesia within 15 minutes in all but one case. Carprofen provided profound analgesia which was as effective and of longer duration than that produced by papaveretum, and was associated with significantly less postoperative sedation and a quicker return to the normal conscious state.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Carbazoles/pharmacology , Dogs/surgery , Opium/pharmacology , Pain, Postoperative/veterinary , Anesthesia, Inhalation/veterinary , Anesthesia, Intravenous/veterinary , Animals , Female , Hypnotics and Sedatives/pharmacology , Male , Pain Measurement/veterinary , Pain, Postoperative/prevention & control , Premedication/veterinary , Random AllocationABSTRACT
The present study was designed to evaluate the effect of repeated oral administration of cryptopine at differential dosing regimens (50, 100, 150, 200 mg/kg bwt) in vivo on lipid peroxide measures, glutathione levels (GSH) and activity of glutathione S-transferase (GST) and glutathione reductase (GR) in the liver, spleen, kidney and lung of Male Wistar rats after a 5 day treatment period. In all the tissues examined, we observed an increase in lipid peroxidation and a decline in glutathione content and activity of glutathione S-transferase and glutathione reductase in a dose-dependent manner. The decrease in GSH content did not definitively correlate with a concomitant increase of lipid peroxidation in all the tissues. Our results ensemble that the enhancement of lipid peroxidation in the tissues investigated is a consequence of depletion of glutathione to certain critical levels and impairment of the glutathione-dependent enzyme systems viz. GST and GR. Our study potentiates that decreased levels of GSH may lead to lipid peroxidation, one of the key events in cellular damage. The inhibition of GST also suggests that the detoxification of the alkaloid could be suppressed following acute exposures. Conclusively, it appears that cryptopine in vivo disturbs the cellular defense system, so that it tips in the direction of autoxidative lipid peroxidation, producing cytotoxicity.
Subject(s)
Alkaloids/pharmacology , Glutathione/metabolism , Lipid Peroxidation/drug effects , Opium/analogs & derivatives , Opium/pharmacology , Alkaloids/chemistry , Animals , Dose-Response Relationship, Drug , Glutathione/antagonists & inhibitors , Lipid Peroxidation/physiology , Male , Rats , Rats, WistarABSTRACT
Endogenous and exogenous opioids can influence and modulate neuronal and glial cell function via an opioid receptor mediated mechanism, leading to either protection or damage of the brain. Opiates such as morphine have been postulated to promote the progression of HIV-1 and the development of secondary opportunistic infections. Kappa opioid receptor ligands, on the other hand, may play a neuroprotective role. More studies are needed to delineate how opioids exert their effects on glial cells as well as neurons with the goal of developing new therapeutic approaches for neurodegenerative disease.
Subject(s)
Brain/physiology , Opioid Peptides/physiology , Receptors, Opioid, kappa/physiology , Receptors, Opioid/physiology , Adjuvants, Immunologic , Endorphins/physiology , HIV Infections/immunology , Humans , Morphine/pharmacology , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Opium/pharmacologyABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: Past practices of compound drugs from different plant ingredients enjoyed remarkable longevity over centuries yet are largely dismissed by modern science as subtherapeutic, lethal or fanciful. AIM OF THE STUDY: To examine the phytochemical content of a popular medieval opiate drug called the "Great Rest" and gauge the bioavailability and combined effects of its alkaloid compounds (morphine, codeine, hyoscyamine, scopolamine) on the human body according to modern pharmacokinetic and pharmacodynamic parameters established for these compounds. CALCULATIONS AND THEORY: We reviewed the most recent studies on the pharmacodynamics of morphine, codeine, hyoscyamine and scopolamine to ascertain plasma concentrations required for different physiological effects and applied these findings to dosage of the Great Rest. RESULTS: Given the proportional quantities of the alkaloid rich plants, we calculate the optimal dose of Great Rest to be 3.1±0.1-5.3±0.76 g and reveal that the lethal dose of Great Rest is double the therapeutic concentration where all three alkaloid compounds are biologically active. CONCLUSION: This study helps establish the effective dose (ED50), toxic dose (TD50) and lethal dose (LD50) rates for the ingestion of raw opium, henbane and mandrake, and describes their probable combined effects, which may be applied to similar types of pre-modern pharmaceuticals to reveal the empirical logic behind past practices.
Subject(s)
Alkaloids/administration & dosage , Analgesics, Opioid/administration & dosage , Hypnotics and Sedatives/administration & dosage , Alkaloids/history , Alkaloids/pharmacology , Analgesics, Opioid/history , Analgesics, Opioid/pharmacology , Dose-Response Relationship, Drug , History, Medieval , Humans , Hyoscyamus/chemistry , Hypnotics and Sedatives/history , Hypnotics and Sedatives/pharmacology , Mandragora/chemistry , Opium/administration & dosage , Opium/history , Opium/pharmacologyABSTRACT
Illicit drug use can be an important cause of male infertility. The aim of this study was to investigate the effects of an Iranian illicit drug, Kerack, on sperm parameters, testicular structure and CatSper genes expression of mice. In this study, 25 male mice were divided into five groups consisting of control, sham and three experimental groups. All animal in experimental groups were addicted to Kerack for 7 days. These experimental groups include experimental I which was given Kerack at a dose of 5 mg/kg, experimental II, 35 mg/kg and experimental III, 70 mg/kg, intraperitoneally twice a day for a period of 35 days. Mice were then sacrificed and spermatozoas were removed from cauda epididymis and analyzed for count, motility, morphology (normal/abnormal) and viability. Right testes were removed, weighed and processed for light microscopic studies whereas left testes removed were subjected to total mRNA extraction for using in real-time PCR (RT-PCR). The results were analyzed by performing anova (Tukey's tests) and Pearson correlation coefficient. Sperm parameters and seminiferous epithelium thickness were decreased in experimental groups (dose-dependently) vs. sham and control groups (p < 0.05). RT-PCR results showed that CatSper 2, 3, 4 genes expressions were reduced with 35 and 70 mg/kg injected Kerack when compared with control testes (p ≤ 0.05). However, CatSper1 expression was only reduced with high dose injected Kerack (70 mg/kg) in comparison to control testes (p ≤ 0.05). This study shows the deleterious effects of Kerack used in Iran on testis structure and sperm parameters in general, and particularly sperm morphology in adult mouse. It could down-regulate the expression of CatSper genes, resulting in depression of sperm motility.
Subject(s)
Calcium Channels/biosynthesis , Infertility, Male/chemically induced , Opium/pharmacology , Sperm Motility/drug effects , Spermatozoa/drug effects , Animals , Body Weight/drug effects , Calcium Channels/genetics , Cell Survival/drug effects , Epididymis/cytology , Illicit Drugs/pharmacology , Iran , Male , Mice , Mice, Inbred BALB C , Sperm Count , Spermatozoa/abnormalities , Spermatozoa/physiology , Substance-Related DisordersABSTRACT
Addiction to opium continues to be a major worldwide medical and social problem. The study addressing the association between opium consumption and serum prostate-specific antigen (PSA) level is lacking. We determined the effects of opium consumption on serum PSA levels in opium-addict men. Our study subjects comprised 438 opium-addict men with a mean age of 52.2 ± 6.4 years (group 1). We compared these men with 446 men who did not indicate current or past opium use (group 2). Serum total PSA (tPSA), free PSA (fPSA), % fPSA, and sex hormones were compared between the 2 groups. The mean serum tPSA level was significantly lower in group 1 (1.05 ng/mL) than in controls (1.45 ng/mL) (P = 0.001). Opium consumption was also associated with lower fPSA (P = 0.001) and % fPSA (P = 0.001). Serum free testosterone level in opium-addict patients (132.5 ± 42 pg/mL) was significantly lower than that in controls (156.2 ± 43 pg/mL) (P = 0.03). However, no significant correlation existed between tPSA and free testosterone levels (r = 0.28, 95% CI, -0.036 to 0.51, P = 0.34). Among the patients with cancer in group 1, 35% were found to have high-grade tumor (Gleason score ≥ 7) compared with 26.7% in group 2 (P = 0.02). Total PSA and fPSA were strongly correlated with duration of opium use (r = -0.06, 95% CI, -0.04 to -0.08, P = 0.0001; and r = -0.05, 95% CI, -0.03 to -0.07, P = 0.0001, respectively). Opium consumption is independently and negatively associated with serum tPSA, fPSA, and % fPSA levels.